Spray to prevent the flu. FDA approves the FluMist vaccine from Astrazeneca (AZN.US).
Spray against influenza! FDA approves the astrazeneca vaccine
Novartis' Pluvicto Expected to Dominate Prostate Cancer Radiopharmaceutical Market
Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights
Astrazeneca (AZN.US) nasal spray flu vaccine has been approved in the USA.
The US Food and Drug Administration announced on Friday that it has approved the astrazeneca (AZN.US) nasal spray flu vaccine FluMist for self-injection, making it the first of its kind in this category of vaccines. The regulatory institutions stated that FluMist is the first vaccine for preventing flu that does not require administration by medical care providers. The company plans to provide FluMist through third-party online pharmacies, and customers must undergo screening and qualification assessments when ordering.
US FDA Approves AstraZeneca's Flu Vaccine for Self-administration
AstraZeneca: Poised for Growth With Promising Innovation Pipeline and Attractive Valuation
AstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market Position
AstraZeneca's Fasenra to Challenge GSK's Nucala in Rare Vasculitis After FDA Nod
Wall Street Bulls Look Optimistic About Astrazeneca (AZN): Should You Buy?
AstraZeneca's Fasenra Meets Primary Endpoint in Phase III Rare Vasculitis Trial
AIM ImmunoTech Sees Promising Results in Ampligen Combo for Pancreatic Cancer
Could The Market Be Wrong About AstraZeneca PLC (LON:AZN) Given Its Attractive Financial Prospects?
BenevolentAI Interim Results for the Six Months Ended 30 June 2024
Press Release: BenevolentAI Interim Results for the Six Months Ended 30 June 2024
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
AstraZeneca Fasenra Gains Additional Indication
AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
AstraZeneca: Strong Oncology Pipeline Fuels Growth and Outperformance – Buy Rating Endorsed
Express News | Xuantai Pharmaceutical: Dapagliflozin Metformin Sustained-release Tablets Approved by the National Medical Products Administration
US FDA Approves AstraZeneca's Fasenra to Treat Rare, Immune-mediated Vasculitis EGPA